Issuu on Google+

ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email!

Global Markets for Infectious Disease Treatments Published on May 2013

Report Summary STUDY GOALS AND OBJECTIVES Infectious diseases are one of the major causes of global morbidity and mortality. Viral, bacterial, parasitic and fungal diseases have plagued humankind for centuries, and our attempts to control these diseases have met with great success. Diseases that were once death sentences are now chronic and manageable diseases. But as with every ongoing story, microbes have transformed themselves to outwit current medications, and the battle to rid humans of the most virulent of diseases continues. With the constant combining and reinvention of microbes comes an urgent need for improved antibiotic and viral medications to sustain the progress made in addressing the most aggressive of infectious diseases. Under these circumstances, there is need for a current and comprehensive report on infectious diseases covering diagnosis, treatment, demand trends, opportunities, and emerging technologies. This study gives a clear, quantitative picture of the supply-and-demand scenario, and it highlights the technological and investment opportunities in the field. REASONS FOR DOING THE STUDY This report provides the reader with a detailed analysis of the global infectious disease market, with emphasis on seven major infectious diseases (i.e., human immunodeficiency virus/acquired immunodeficiency virus [HIV/AIDS]; hepatitis A, B, C; malaria, rotavirus/diarrhea; measles; pneumonia; and tuberculosis [TB]). The report also discusses technological developments, future trends, and emerging opportunities. The major objectives of this study are: ' Assessing the current state of infectious diseases on a global basis. ' Identifying the driving factors for demand of new diagnostic and pharmaceutical products. ' Estimating current and future market sizes for diagnostic and pharmaceutical infectious disease products. ' Estimating the current global supply-and-demand scenario, by disease type and geographical regions. ' Identifying factors that influence the industry and proposing market opportunities. SCOPE OF REPORT The market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and diagnostic products, and an applicable patents section. Information is organized by type of infectious disease (i.e., bacterial, viral, parasitic) and appropriate treatments, both current and anticipated. INTENDED AUDIENCE

Global Markets for Infectious Disease Treatments (From Issuu)

Page 1/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! This updated version on the infectious disease market and technologies will be a valuable tool for decision makers and manufacturers in both the diagnostic and the pharmaceutical treatment industries. Individuals at research foundations, manufacturing companies, and university laboratories will find valuable information on the global diagnostic product and pharmaceutical industries. This information will also be useful for individuals involved in strategic planning and marketing and sales development. The audience will obtain a broad view of the social and economic consequences of infectious diseases. Additionally, emphasis on the type of disease, major players in the marketplace, market conditions, and current and projected revenues will be provided. METHODOLOGIES AND INFORMATION SOURCES The data for this report were gathered from primary and secondary sources. Sources include information obtained from industry analysis, manufacturers, academic and trade journals, and industry associations. Additional sources include the U.S. Patent and Trademark Office (USPTO), U.S. Securities and Exchange Commission (SEC) filings, the World Health Organization (WHO), the Centers for Disease Control (CDC), the Mayo Clinic, the Pharmaceutical Research and Manufacturing Association, and UNAIDS. Where precise information was not available, a projection was made using reasonable assumptions and estimates based on historical data. All market data are based on manufacturers' sales. ANALYST CREDENTIALS Peggy Lehr is the BCC Research analyst for this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and an MS in Communication from the University of Denver. Ms. Lehr has worked as a researcher, editor, and publisher within the publishing industry for both for-profit and not-for-profit organizations. She is the author of several BCC reports dealing with healthcare, pharmaceuticals, and agriculture. REPORT HIGHLIGHTS This report provides: ' An overview of the global market for infectious disease treatments, with a focus on the growth in demand for newer pharmaceutical treatments, vaccines, and environmental products ' Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017 ' Discussion of the increasing concern regarding antibiotic-resistant organisms and their sometimes-fatal effects on humans ' Examination of technological developments, future trends, and emerging opportunities ' Assessments of the current state of infectious diseases on a global basis, broken down by type of disease (i.e., bacterial, viral, parasitic, and fungal) and appropriate treatments, both current and anticipated, and by geographic region ' Patent analysis ' Comprehensive company profiles of major players.

Table of Content TABLE OF CONTENTS

Global Markets for Infectious Disease Treatments (From Issuu)

Page 2/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! CHAPTER 1 INTRODUCTION 2 STUDY GOALS AND OBJECTIVES 2 REASONS FOR DOING THE STUDY 2 SCOPE OF REPORT 2 INTENDED AUDIENCE 3 METHODOLOGIES AND INFORMATION SOURCES 3 ANALYST CREDENTIALS 3 RELATED BCC REPORTS 3 BCC ON-LINE SERVICES 4 DISCLAIMER 4 CHAPTER 2 SUMMARY 6 SUMMARY TABLE PROJECTED MARKET FOR INFECTIOUS DISEASES DIAGNOSTIC, VACCINE AND PHARMACEUTICAL PRODUCTS BY TYPE, THROUGH 2017 ($ MILLIONS) 7 SUMMARY FIGURE PERCENTAGE OF MARKET SHARE FOR INFECTIOUS DISEASE DIAGNOSTIC, VACCINE AND PHARMACEUTICAL PRODUCTS BY GEOGRAPHIC REGION, 2012 AND 2017 (%) 8 CHAPTER 3 OVERVIEW OF THE GLOBAL STATE OF INFECTIOUS DISEASE DIAGNOSIS, VACCINES, AND TREATMENT 10 TOP GLOBAL CAUSES OF DEATH 10 TABLE 1 GLOBAL PERCENTAGE OF DEATHS BY TYPE OF DISEASE, CAUSE, INCOME LEVEL (%) 11 MAJOR INFECTIOUS DISEASES 11 TABLE 2 SELECTED MAJOR INFECTIOUS DISEASES, WORLDWIDE, 2011 (NUMBER OF CASES, TREATMENT OPTIONS) 11 HISTORICAL IMPACT OF INFECTIOUS DISEASES 12 LEADING CAUSES OF GLOBAL DEATHS 13 Transmission of Infectious Diseases 13 LINKING INFECTIOUS DISEASE TO CANCER 13 TREATMENTS FOR INFECTIOUS DISEASES 13 PREVENTION 13 VACCINATION 14 FIGURE 1 VACCINE-PREVENTABLE DEATHS IN CHILDREN UNDER FIVE YEARS OF AGE, 2008 (THOUSANDS) 14 TABLE 3 VACCINE-PREVENTABLE DISEASE DEATHS IN CHILDREN UNDER 5 YEARS OF AGE BY REGION, 2008 (000) 15 GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET 15 TYPES OF DIAGNOSTIC TESTING 15 FLUORESCENT IMMUNOASSAY (FIA) 16 Direct Fluorescent Antibody Testing (FA) 16 Indirect Fluorescent Antibody Testing (IFA) 16 Chemiluminescent Microparticle Immunoassay (CIA) 16 ENZYME IMMUNOASSAY (EIA) 16 Basic EIA 17

Global Markets for Infectious Disease Treatments (From Issuu)

Page 3/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Enzyme-Linked Immunosorbent Assay (ELISA) 17 GENE PROBE ANALYSIS 17 Polymerase Chain Reaction Amplification (PCR) 18 Nucleic Acid Amplification Test (NAT) 18 Transcription-Mediated Amplification (TMA) 18 Nucleic Acid Sequence-Based Amplification (NASBA) 19 GLOBAL MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS 19 TABLE 4 PROJECTED GLOBAL MARKET FOR HUMAN INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS, THROUGH 2017 ($ MILLIONS) 19 GLOBAL INFECTIOUS DISEASE VACCINE MARKET 19 TABLE 5 PROJECTED GLOBAL MARKET FOR HUMAN INFECTIOUS DISEASE VACCINE PRODUCTS, THROUGH 2017 ($ MILLIONS) 20 THE GLOBAL INFECTIOUS DISEASE PHARMACEUTICAL MARKET 20 TABLE 6 PROJECTED GLOBAL MARKET FOR HUMAN INFECTIOUS DISEASE PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 20 PROJECTIONS FOR GLOBAL INFECTIOUS DISEASE PRODUCTS BY TYPE AND DISEASE 21 TABLE 7 PROJECTED GLOBAL MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC, VACCINE AND TREATMENT PRODUCTS, THROUGH 2017 ($ MILLIONS) 21 VACCINE OPPORTUNITIES 22 CHILDHOOD DISEASES 22 GLOBAL HUMANITARIAN AGENCIES 22 PHARMACEUTICAL OPPORTUNITIES 23 THE EMERGENCE OF GENE THERAPY 23 MERGERS AND ACQUISITIONS 24 TABLE 8 SELECTED MERGERS AND ACQUISITIONS, 2008-2013 ($ MILLIONS) 24 CHAPTER 4 VACCINES-THE PRESENT AND THE FUTURE 26 MARKET FOR HUMAN INFECTIOUS DISEASE VACCINES 26 TABLE 9 PROJECTED GLOBAL MARKET FOR INFECTIOUS DISEASE VACCINES, THROUGH 2017 ($ MILLIONS) 26 TYPES OF VACCINES 27 LIVE ATTENUATED VACCINE 27 INACTIVATED VACCINE 27 Acellular/Subunit Vaccines 27 IMMUNITY 27 INNATE IMMUNITY 28 ACQUIRED IMMUNITY 28 The Activity of T Cells 28 Acquired Immunity-Cell-Mediated Response 29 LASTING IMMUNITY 29 VIRAL DISEASES PREVENTED BY VACCINE 29 TABLE 10 VIRUSES, THE DISEASES THEY CAUSE, AND AVAILABLE VACCINES 29 BACTERIAL DISEASES PREVENTED BY VACCINE 30 TABLE 11 BACTERIA, THE DISEASES THEY CAUSE, AND AVAILABLE VACCINES 30 VACCINATION SCHEDULES FOR CHILDREN 30 TABLE 12 IMMUNIZATION SCHEDULE FOR CHILDREN FROM BIRTH TO 6 MONTHS 31

Global Markets for Infectious Disease Treatments (From Issuu)

Page 4/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! TABLE 13 IMMUNIZATION SCHEDULE FOR CHILDREN FROM 12 MONTHS TO 4 TO 6 YEARS 31 TABLE 14 IMMUNIZATION SCHEDULE FOR CHILDREN AND ADOLESCENTS FROM 7 TO 18 32 CONCERNS REGARDING VACCINATION IN CHILDHOOD 32 NUMBER OF INOCULATIONS 32 RECOGNIZING IMMUNE RESPONSE 32 IMMUNIZATION AND WEAKENED OR ALTERED IMMUNE SYSTEMS 33 VACCINE PRODUCTION 33 FIGURE 2 VACCINE MANUFACTURING PROCESS 33 VACCINE MANUFACTURERS 34 TOP- SELLING VACCINES OF 2011 35 TABLE 15 TOP-SELLING INFECTIOUS DISEASE VACCINES WITH APPLICATION, MANUFACTURER AND REVENUE, 2011 35 REGIONAL ANALYSIS 35 TABLE 16 PROJECTED REGIONAL MARKETS FOR VACCINES, THROUGH 2017 ($ MILLIONS) 35 FIGURE 3 PERCENTAGE OF MARKET SHARE FOR VACCINES BY REGION, 2012 AND 2017 36 THE AMERICAS 37 TABLE 17 PROJECTED AMERICAS MARKET FOR INFECTIOUS DISEASE VACCINES BY REGION, THROUGH 2017 ($ MILLIONS) 37 TABLE 18 PROJECTED AMERICAS MARKET FOR INFECTIOUS DISEASE VACCINES BY DISEASE, THROUGH 2017 ($ MILLIONS) 38 EMRA 38 TABLE 19 PROJECTED EMRA MARKET FOR HUMAN INFECTIOUS DISEASE VACCINES, BY REGION, THROUGH 2017 ($ MILLIONS) 38 TABLE 20 PROJECTED EMRA MARKET FOR HUMAN INFECTIOUS DISEASE VACCINES, BY DISEASE, THROUGH 2017 ($ MILLIONS) 39 ASIA 39 TABLE 21 PROJECTED ASIAN MARKET FOR HUMAN INFECTIOUS DISEASE VACCINES, BY REGION, THROUGH 2017 ($ MILLIONS) 39 TABLE 22 PROJECTED ASIAN MARKET FOR HUMAN INFECTIOUS DISEASE VACCINES, BY DISEASE, THROUGH 2017 ($ MILLIONS) 40 TRENDS IN VACCINE DEVELOPMENT 40 COMBINATION VACCINES 40 INHALED OR INTRANASAL VACCINE ADMINISTRATION 40 CHAPTER 5 VIRAL INFECTIOUS DISEASES 43 GLOBAL MARKET FOR VIRAL INFECTIOUS DISEASE DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS 43 TABLE 23 PROJECTED GLOBAL MARKET FOR VIRAL INFECTIOUS DISEASE DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 43 HEPATITIS B AND C 43 TABLE 24 PROJECTED GLOBAL MARKET FOR HEPATITIS DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 44 RISK FACTORS 44

Global Markets for Infectious Disease Treatments (From Issuu)

Page 5/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! TREATMENTS 44 HERPES SIMPLEX VIRUS 45 TABLE 25 PROJECTED GLOBAL MARKET FOR HSV DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 45 INCIDENCE 45 DIAGNOSIS 46 TABLE 26 CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF GENITAL HERPES BY BRAND NAME, TYPE AND MANUFACTURER, 2012 46 TREATMENT 47 TABLE 27 MEDICATIONS USED TO TREAT HSV BY BRAND NAME, GENERIC NAME AND MANUFACTURER 47 HEPATITIS B AND C 48 TABLE 28 PROJECTED GLOBAL MARKET FOR HEPATITIS B AND C DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 48 DIAGNOSIS 48 TABLE 29 HEPATITIS B AND C DIAGNOSTIC PRODUCT MARKET SHARE BY TYPE OF TEST AND REVENUES, 2011 ($ MILLIONS/%) 48 TABLE 30 CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF HEPATITIS B AND C BY BRAND NAME AND MANUFACTURER, 2012 49 Automated Infectious Disease Testing for Hepatitis 50 TREATMENT MARKET 50 TABLE 31 HEPATITIS B AND C TREATMENT MANUFACTURER MARKET STANDING, BY REVENUES, 2011 ($ MILLIONS) 51 FIGURE 4 TOP PHARMACEUTICAL MANUFACTURERS IN THE HEPATITIS MARKET AND THEIR MARKET SHARE, 2011 (%) 51 TABLE 32 MEDICATIONS FOR THE TREATMENT OF HEPATITIS B AND C, 2012 52 HIV/AIDS 52 TABLE 33 PROJECTED GLOBAL MARKET FOR HIV DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 53 RISK FACTORS 53 INCIDENCE/MORTALITY 54 HAART TREATMENT 54 HAART Failure 55 Mega-HAART 55 HIV TREATMENT FOR INFANTS 55 HUMAN PAPILLOMAVIRUS 55 HPV AND CANCER 55 INCIDENCE 56 SYMPTOMS 56 DIAGNOSIS 56 TABLE 34 CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF HPV BY BRAND NAME, TYPE AND MANUFACTURER, 2012 57 TREATMENT 57 TABLE 35 MEDICATIONS USED TO TREAT HPV BY BRAND NAME, GENERIC NAME, AND MANUFACTURER 57 INFLUENZA A AND B 57 VACCINE 58 TREATMENT 58

Global Markets for Infectious Disease Treatments (From Issuu)

Page 6/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! MEASLES 58 PNEUMONIA 58 BACTERIAL PNEUMONIA 58 Vaccine 59 Treatment 59 VIRAL PNEUMONIA 59 Treatment 59 ROTAVIRUS 59 DEHYDRATION 60 ZINC 60 RSV 60 SYMPTOMS 60 DIAGNOSTIC PRODUCTS 61 TABLE 36 RSV DIAGNOSTIC PRODUCTS BY BRAND NAME, MANUFACTURER AND TYPE 2012 61 VIRAL DIAGNOSTIC PRODUCTS 61 TABLE 37 PROJECTED GLOBAL MARKET FOR VIRAL INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS, THROUGH 2017 ($ MILLIONS) 62 VIRAL PHARMACEUTICAL PRODUCTS 62 TABLE 38 PROJECTED GLOBAL MARKET FOR VIRAL INFECTIOUS DISEASE PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 62 REGIONAL ANALYSIS 63 TABLE 39 PROJECTED GLOBAL MARKET FOR VIRAL INFECTIOUS DISEASE DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 63 FIGURE 5 PERCENTAGE OF THE GLOBAL VIRAL DIAGNOSTIC AND PHARMACEUTICAL MARKETS BY REGIONS, 2012 AND 2017 (%) 63 TABLE 40 PROJECTED MARKET FOR VIRAL DIAGNOSTIC PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 64 TABLE 41 PROJECTED MARKET FOR VIRAL PHARMACEUTICAL PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 65 AMERICAS 65 Hepatitis B in the U.S. 65 Hepatitis C in the U.S. 66 Hepatitis in Canada 66 Market for Viral Infectious Disease Products in the Americas 66 TABLE 42 PROJECTED AMERICAS MARKET FOR VIRAL INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 66 TABLE 43 PROJECTED AMERICAS MARKET FOR VIRAL INFECTIOUS DISEASE PHARMACEUTICAL PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 67 Americas Diagnostic and Pharmaceutical Products Market, by Disease 67 TABLE 44 PROJECTED AMERICAS MARKET FOR VIRAL INFECTIOUS DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, BY DISEASE, THROUGH 2017 ($ MILLIONS) 67 EMRA 67 Hepatitis B, C in EMRA 67 Hepatitis in Africa 68

Global Markets for Infectious Disease Treatments (From Issuu)

Page 7/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Hepatitis in Russia, Eurasia 68 Market for Viral Infectious Disease Diagnostic and Pharmaceutical Products 68 TABLE 45 PROJECTED EMRA MARKET FOR VIRAL INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 68 TABLE 46 PROJECTED EMRA MARKET FOR VIRAL INFECTIOUS DISEASE PHARMACEUTICAL PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 69 EMRA Market for Infectious Disease Diagnostic and Pharmaceutical Products, by Disease 69 TABLE 47 PROJECTED EMRA MARKET FOR VIRAL INFECTIOUS DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, BY DISEASE, THROUGH 2017 ($ MILLIONS) 70 ASIA 70 Hepatitis in Asian Region 70 Hepatitis in Japan 70 Hepatitis in China 70 Hepatitis in India 71 TABLE 48 PROJECTED ASIAN MARKET FOR VIRAL INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 71 TABLE 49 PROJECTED ASIAN MARKET FOR VIRAL INFECTIOUS DISEASE PHARMACEUTICAL PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 71 TABLE 50 PROJECTED ASIAN MARKET FOR VIRAL INFECTIOUS DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, BY DISEASE, THROUGH 2017 ($ MILLIONS) 72 CHAPTER 6 BACTERIAL INFECTIOUS DISEASES AND THE SPECTER OF ANTIBIOTIC RESISTANCE 74 NEGLECTED TROPICAL BACTERIAL INFECTIOUS DISEASES 74 TABLE 51 NEGLECTED TROPICAL BACTERIAL INFECTIOUS DISEASES 74 MARKET FOR BACTERIAL INFECTIOUS DISEASES DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS 74 TABLE 52 PROJECTED GLOBAL MARKET FOR BACTERIAL INFECTIOUS DISEASES DIAGNOSTIC AND TREATMENT PRODUCTS, THROUGH 2017 ($ MILLIONS) 75 MARKET FOR BACTERIAL INFECTIOUS DISEASE DIAGNOSTICS 75 TABLE 53 PROJECTED GLOBAL MARKET FOR BACTERIAL INFECTIOUS DISEASES DIAGNOSTICS, THROUGH 2017 ($ MILLIONS) 75 MARKET FOR BACTERIAL INFECTIOUS DISEASES PHARMACEUTICALS 76 TABLE 54 PROJECTED GLOBAL MARKET FOR BACTERIAL INFECTIOUS DISEASES PHARMACEUTICALS, THROUGH 2017 ($ MILLIONS) 76 NOTABLE BACTERIAL DISEASES 76 CORYNEBACTERIUM DIPHTHERIAE, CLOSTRIDIUM TETANI, BORDETELLA PERTUSSIS 76 Diphtheria 76 Tetanus 77 Pertussis 77 MENINGITIS 77 MYCOBACTERIUM TUBERCULOSIS (TB) 78 TABLE 55 PROJECTED GLOBAL MARKET FOR TB DIAGNOSTIC AND PHARMACEUTICAL TREATMENTS, THROUGH 2017 ($ MILLIONS) 78

Global Markets for Infectious Disease Treatments (From Issuu)

Page 8/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! EPIDEMIOLOGY OF TB 78 GEOGRAPHIC PREVALENCE 79 TABLE 56 PROJECTED MARKET FOR TB DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, BY REGION, THROUGH 2017 ($ MILLIONS) 79 FINANCING CONTROL EFFORTS 80 ANTIBIOTIC DEVELOPMENT 80 TABLE 57 HISTORY OF ANTIBIOTIC DISCOVERY AND APPROVAL 80 TABLE 58 ANTIBIOTIC CLASSES AND THEIR MODE OF ACTION 81 ANTIBIOTIC RESISTANCE 81 MECHANISMS OF RESISTANCE 82 METHODS OF RESISTANCE 83 Beta-Lactamase Production 83 Importing Resistance from Other Organisms 83 Examples of Antibiotic-Resistant Bacteria 84 Alteration of Binding Sites to Circumvent Anti-Infective Effectiveness 84 Antibiotic Discharge 84 PRIMARY REASONS FOR ANTIBIOTIC RESISTANCE 85 FAILURE TO FINISH ANTIBIOTIC COURSES 85 ANTIBIOTIC OVERUSE 85 AGRICULTURAL PRACTICES 85 TABLE 59 ANTIBIOTICS APPROVED FOR USE IN FOOD-PRODUCING ANIMALS IN 2009, BY DRUG CLASS, POUNDS USED, AND PERCENTAGE OF TOTAL (POUNDS/%) 86 PATIENT PRESSURE 86 INTERNATIONAL SURVEILLANCE OF ANTIBIOTIC-RESISTANT ORGANISMS 87 RESISTANCE BY CLASS OF ANTIBIOTIC 87 TABLE 60 ANTIBIOTIC-RESISTANT ORGANISMS AND DRUG CLASSES AFFECTED 87 INCIDENCES OF ANTIBIOTIC RESISTANCE 87 ANTIBIOTIC RESISTANCE IN EUROPE 87 ANTIBIOTIC RESISTANCE IN THE U.S. 88 MAJOR ANTIBIOTIC-RESISTANT ORGANISMS 88 VANCOMYCIN-RESISTANT ENTEROCOCCUS (VRE) 88 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) 88 CLOSTRIDIUM DIFFICILE (C. DIFFICILE) 89 REGIONAL ANALYSIS 89 TABLE 61 PROJECTED GLOBAL MARKET FOR BACTERIAL DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 89 FIGURE 6 MARKET SHARE OF BACTERIAL INFECTIOUS DISEASES DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS BY REGION, 2012 AND 2017 (%) 89 THE AMERICAS 90 TABLE 62 PROJECTED AMERICAS MARKET FOR BACTERIAL DIAGNOSTIC AND PHARMACEUTICAL TREATMENTS, THROUGH 2017 ($ MILLIONS) 91 Bacterial Infection Diagnostic Product Market in the Americas 91 TABLE 63 BACTERIAL INFECTIOUS DISEASES DIAGNOSTIC PRODUCT MARKET IN THE AMERICAS BY REGION, THROUGH 2017 ($ MILLIONS) 91 Bacterial Infection Pharmaceutical Market in the Americas 91 TABLE 64 BACTERIAL INFECTION PHARMACEUTICAL PRODUCT MARKET IN THE AMERICAS, BY REGION, THROUGH 2017 ($ MILLIONS) 91 Americas Bacterial Infectious Diseases Diagnostic and

Global Markets for Infectious Disease Treatments (From Issuu)

Page 9/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Pharmaceutical Market, by Disease 92 TABLE 65 PROJECTED AMERICAS MARKET FOR BACTERIAL INFECTIOUS DISEASES DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, BY DISEASE, THROUGH 2017 ($ MILLIONS) 92 EMRA 93 TABLE 66 PROJECTED EMRA MARKET FOR BACTERIAL INFECTIOUS DISEASES DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 93 Bacterial Infectious Diseases Diagnostic Market in EMRA 93 TABLE 67 BACTERIAL INFECTIOUS DISEASES DIAGNOSTIC PRODUCT MARKET IN EMRA BY REGION, THROUGH 2017 ($ MILLIONS) 94 Bacterial Infectious Diseases Pharmaceutical Product Market in EMRA 94 TABLE 68 BACTERIAL INFECTIOUS DISEASES PHARMACEUTICAL PRODUCT MARKET IN EMRA BY REGION, THROUGH 2017 ($ MILLIONS) 94 EMRA Bacterial Infectious Diseases Diagnostic and Pharmaceutical Market, by Disease 94 TABLE 69 PROJECTED EMRA MARKET FOR BACTERIAL INFECTIOUS DISEASES DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS BY DISEASE, THROUGH 2017 ($ MILLIONS) 94 ASIA 95 TABLE 70 PROJECTED ASIA MARKET FOR BACTERIAL INFECTIOUS DISEASES DIAGNOSTIC AND PHARMACEUTICAL TREATMENTS, THROUGH 2017 ($ MILLIONS) 96 Bacterial Infectious Diseases Diagnostic Product Market in Asia 96 TABLE 71 BACTERIAL INFECTIOUS DISEASES DIAGNOSTIC PRODUCT MARKET IN ASIA BY REGION, THROUGH 2017 ($ MILLIONS) 96 Bacterial Infectious Diseases Pharmaceutical Product Market in Asia 97 TABLE 72 BACTERIAL INFECTIOUS DISEASES PHARMACEUTICAL PRODUCT MARKET IN ASIA, BY REGION, THROUGH 2017 ($ MILLIONS) 97 Asian Bacterial Infectious Diseases Diagnostic and Pharmaceutical Market, by Disease 97 TABLE 73 PROJECTED ASIAN MARKET FOR BACTERIAL INFECTIOUS DISEASES DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, BY DISEASE, THROUGH 2017 ($ MILLIONS) 97 CHAPTER 7 PARASITIC INFECTIOUS DISEASES 99 NEGLECTED TROPICAL PARASITIC INFECTIOUS DISEASES 99 TABLE 74 NEGLECTED TROPICAL PARASITIC INFECTIOUS DISEASES 99 CLIMATE CHANGE AND VECTOR-BORNE DISEASES 99 MALARIA 100 INCIDENCES OF MALARIA 100 TABLE 75 ESTIMATED 2010 GLOBAL MALARIA CASES AND ESTIMATED DEATHS, RATE OF DECREASE OF MALARIA DEATHS SINCE 2000, BY REGION* 101 CAUSES OF MALARIA 101 SYMPTOMS OF MALARIA 101 GLOBAL MARKET FOR MALARIAL PREVENTION, DIAGNOSTIC AND

Global Markets for Infectious Disease Treatments (From Issuu)

Page 10/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! PHARMACEUTICAL TREATMENTS 101 TABLE 76 PROJECTED GLOBAL MARKET FOR MALARIAL PREVENTION, DIAGNOSTIC AND PHARMACEUTICAL TREATMENTS, THROUGH 2017 ($ MILLIONS) 102 INTERVENTIONAL TECHNIQUES TO MINIMIZE EXPOSURE TO MALARIAL VECTORS 102 TABLE 77 PROJECTED GLOBAL MARKET FOR INSECTICIDE-TREATED NETS, THROUGH 2017 ($ MILLIONS) 102 DIAGNOSIS OF MALARIA 103 TABLE 78 PROJECTED GLOBAL MARKET FOR MALARIAL DIAGNOSTIC PRODUCTS, THROUGH 2017 ($ MILLIONS) 103 TREATMENT OF MALARIA 103 TABLE 79 CURRENT PHARMACEUTICALS FOR TREATMENT OF MALARIA, WITH TREATMENT AND MANUFACTURER, 2012 104 TABLE 80 PROJECTED GLOBAL MARKET FOR MALARIAL DRUG TREATMENTS, THROUGH 2017 ($ MILLIONS) 104 REGIONAL ANALYSIS 104 REGIONAL ANALYSIS 105 TABLE 81 PROJECTED GLOBAL MARKET FORMAL ARIAL PREVENTION, DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 105 FIGURE 7 GLOBAL MARKET FOR MALARIAL TREATMENTS BY REGION 2012 AND 2017 (%) 105 THE AMERICAS 106 TABLE 82 PROJECTED AMERICAS MARKET FOR MALARIAL PREVENTION, DIAGNOSTIC AND PHARMACEUTICAL TREATMENTS, THROUGH 2017 ($ MILLIONS) 107 Malarial Prevention Product Market in the Americas 107 TABLE 83 MALARIAL PREVENTION PRODUCT MARKET IN THE AMERICAS BY REGION, THROUGH 2017 ($ MILLIONS) 107 Malarial Diagnostic Product Market in the Americas 107 TABLE 84 MALARIAL DIAGNOSTIC PRODUCT MARKET IN THE AMERICAS BY REGION, THROUGH 2017 ($ MILLIONS) 108 Malarial Pharmaceutical Market in the Americas 108 TABLE 85 MALARIAL PHARMACEUTICAL PRODUCT MARKET IN THE AMERICAS BY REGION, THROUGH 2017 ($ MILLIONS) 108 EMRA 108 TABLE 86 PROJECTED EMRA MARKET FOR MALARIAL PREVENTIVE, DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 109 Malarial Prevention Market in the EMRA 109 TABLE 87 MALARIAL PREVENTIVE PRODUCT MARKET IN EMRA, BY REGION, THROUGH 2017 ($ MILLIONS) 109 Malarial Diagnostic Product Market in EMRA 109 TABLE 88 MALARIAL DIAGNOSTIC PRODUCT MARKET IN EMRA, BY REGION, THROUGH 2017 ($ MILLIONS) 110 Malarial Pharmaceutical Product Market in the EMRA 110 TABLE 89 MALARIAL PHARMACEUTICAL PRODUCT MARKET IN THE EMRA, BY REGION, THROUGH 2017 ($ MILLIONS) 110 ASIA 110 TABLE 90 PROJECTED ASIA MARKET FOR MALARIAL PREVENTION, DIAGNOSTIC, AND PHARMACEUTICAL TREATMENTS, THROUGH 2017 ($ MILLIONS) 111

Global Markets for Infectious Disease Treatments (From Issuu)

Page 11/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! TABLE 91 MALARIAL PREVENTION PRODUCT MARKET IN ASIA BY REGION, THROUGH 2017 ($ MILLIONS) 111 TABLE 92 MALARIAL DIAGNOSTIC PRODUCT MARKET IN ASIA BY REGION, THROUGH 2017 ($ MILLIONS) 112 TABLE 93 MALARIAL PHARMACEUTICAL PRODUCT MARKET IN ASIA BY REGION, THROUGH 2017 ($ MILLIONS) 112 TABLE 94 CURRENT ANT PARASITIC PHARMACEUTICALS WITH TRADENAME, GENERIC NAME, MANUFACTURER, AND AREA OF TREATMENT, 2012 113 MARKET FOR ANTIPARASITIC PHARMACEUTICALS 113 CHAPTER 8 EMERGING TECHNOLOGY AND PHARMACEUTICALS 115 HEPATITIS C 115 POLYMERASE 115 Vertex Pharmaceuticals 115 NS5B 115 Roche 115 Boehringer Ingelheim 115 INFLUENZA 115 VAXINNATE 116 HSV 116 MALARIA 117 VACCINE 117 PHARMACEUTICALS 117 DIAGNOSTIC TESTING 117 ANTIBIOTIC RESISTANCE 118 GALAPAGOS NV 118 TRIUS THERAPEUTICS 118 CRESTONE PHARMA 119 BASILEA PHARMACEUTICA 119 POLYPHOR 119 REMPEX PHARMA 119 PHARMACEUTICAL TREATMENT PRODUCT PIPELINE 120 TABLE 95 INFECTIOUS DISEASES PHARMACEUTICAL PRODUCT PIPELINE, BY DISEASE, 2012 120 CHAPTER 9 PATENT ANALYSIS 128 PHARMACEUTICAL PATENTS, BY PATENT NUMBER, DISEASE, COMPANY, DESCRIPTION AND APPROVAL DATE 128 TABLE 96 INFECTIOUS DISEASES PHARMACEUTICAL AND VACCINE PATENTS, BY PATENT NUMBER, DISEASE, COMPANY, PRODUCT DESCRIPTION AND APPROVAL DATE, FEBRUARY 2006 TO FEBRUARY 2013 129 DIAGNOSTIC PATENTS ISSUED, BY COMPANY, APPROVAL DATE, AND DISEASE 141 TABLE 97 INFECTIOUS DISEASES DIAGNOSTIC PATENTS, BY PATENT NUMBER, DISEASE, COMPANY, PRODUCT DESCRIPTION, AND APPROVAL DATE, MARCH 2005-DECEMBER 2012

Global Markets for Infectious Disease Treatments (From Issuu)

Page 12/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 142 PATENTS ISSUED BY COMPANY 142 TABLE 98 INFECTIOUS DISEASES PHARMACEUTICAL, VACCINE, AND DIAGNOSTIC PRODUCT PATENTS BY COMPANY, MARCH 2005-FEBRUARY 2013 143 PATENTS ISSUED BY COUNTRY 144 TABLE 99 INFECTIOUS DISEASE PRODUCT DIAGNOSIS, VACCINE AND TREATMENT PATENTS BY COUNTRY, JANUARY 2005 TO FEBRUARY 2013 (NUMBER/%) 145 FIGURE 8 NUMBER OF INFECTIOUS DISEASES PRODUCT DIAGNOSIS, VACCINE AND TREATMENT PATENTS BY COUNTRY, JANUARY 2005-FEBRUARY 2013 (%) 146 INFECTIOUS DISEASES PATENTS ISSUED, BY DISEASE 146 TABLE 100 PATENTS ISSUED FOR DIAGNOSIS, VACCINE AND TREATMENT OF INFECTIOUS DISEASES, BY DISEASE, MARCH 2005-FEBRUARY 2013 (NUMBER/%) 146 FIGURE 9 INFECTIOUS DISEASES DIAGNOSTIC, VACCINE AND PHARMACEUTICAL PATENTS BY DISEASE ISSUED BETWEEN MARCH 2005 AND DECEMBER 2012, (%) 147 INFECTIOUS DISEASES PATENTS, BY YEAR 147 TABLE 101 NUMBER OF INFECTIOUS DISEASES PATENTS FOR DIAGNOSTIC, VACCINE AND PHARMACEUTICAL PRODUCTS, BY DISEASE AND YEAR, 2005-2013 148 CHAPTER 10 COMPANY PROFILES 150 ABBOTT LABORATORIES 150 BUSINESS OVERVIEW 150 PRODUCTS 150 TABLE 102 ABBOTT PHARMACEUTICAL PRODUCTS 150 DIAGNOSTIC PRODUCTS 151 TABLE 103 ABBOTT DIAGNOSTIC PRODUCTS 151 ALERE 151 BUSINESS OVERVIEW 151 PRODUCTS 152 TABLE 104 ALERE DIAGNOSTIC PRODUCTS 152 ALFA SCIENTIFIC DESIGNS 153 BUSINESS OVERVIEW 153 PRODUCTS 153 TABLE 105 ALFA SCIENTIFIC DESIGNS DIAGNOSTIC PRODUCTS 153 ATLAS LINK BIOTECH CO., LTD. 154 BUSINESS OVERVIEW 154 PRODUCTS 154 TABLE 106 ATLAS LINK BIOTECH DIAGNOSTIC PRODUCTS 154 ASTRA ZENECA 155 BUSINESS OVERVIEW 155 PRODUCTS 155 TABLE 107 ASTRA ZENECA PHARMACEUTICAL PRODUCTS 155 BAXTER HEALTHCARE 155 BUSINESS OVERVIEW 155 PRODUCTS 156 TABLE 108 BAXTER PHARMACEUTICAL PRODUCTS 156 BAYER AG 156 BUSINESS OVERVIEW 156

Global Markets for Infectious Disease Treatments (From Issuu)

Page 13/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! PRODUCTS 156 TABLE 109 BAYER PHARMACEUTICAL PRODUCTS 156 BECTON DICKINSON 157 BUSINESS OVERVIEW 157 PRODUCTS 157 TABLE 110 BECTON DICKINSON DIAGNOSTIC PRODUCTS 157 BIO-RAD LABORATORIES 157 BUSINESS OVERVIEW 157 PRODUCTS 158 TABLE 111 BIORAD DIAGNOSTIC PRODUCTS 158 BOEHRINGER INGELHEIM GMBH 158 BUSINESS OVERVIEW 158 PRODUCTS 159 TABLE 112 BOEHRINGER INGELHEIM PHARMACEUTICAL PRODUCTS 159 BRISTOL-MYERS SQUIBB COMPANY 159 BUSINESS OVERVIEW 159 PRODUCTS 159 TABLE 113 BRISTOL-MYERS SQUIBB PHARMACEUTICAL PRODUCTS 159 CEPHEID 160 BUSINESS OVERVIEW 160 PRODUCTS 160 TABLE 114 CEPHEID DIAGNOSTIC PRODUCTS 160 CRUCELL NV 160 BUSINESS OVERVIEW 161 PRODUCTS 161 TABLE 115 CRUCELL VACCINE PRODUCTS 161 CUBIST PHARMACEUTICALS 162 BUSINESS OVERVIEW 162 PRODUCTS 162 TABLE 116 CUBIST PHARMACEUTICAL PRODUCT 162 DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC. 162 BUSINESS OVERVIEW 162 PRODUCTS 163 TABLE 117 DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS DIAGNOSTIC PRODUCTS 163 DIASORIN 163 BUSINESS OVERVIEW 164 PRODUCTS 164 TABLE 118 DIAGNOSTIC PRODUCTS 164 ENANTA PHARMACEUTICALS 164 BUSINESS OVERVIEW 164 ENZO BIOCHEM 165 BUSINESS OVERVIEW 165 PRODUCTS 165 TABLE 119 ENZO BIOCHEM DIAGNOSTIC PRODUCTS 165 FIRST DIAGNOSTIC LLC 165 BUSINESS OVERVIEW 165 PRODUCTS 166

Global Markets for Infectious Disease Treatments (From Issuu)

Page 14/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! TABLE 120 FIRST DIAGNOSTIC PRODUCTS 166 GILEAD SCIENCES INC. 166 BUSINESS OVERVIEW 166 PRODUCTS 167 TABLE 121 GILEAD SCIENCES PHARMACEUTICAL PRODUCTS 167 GLAXOSMITHKLINE 167 BUSINESS OVERVIEW 167 PRODUCTS 168 TABLE 122 GLAXOSMITHKLINE PHARMACEUTICAL/VACCINE PRODUCTS 168 HOLOGIC GEN-PROBE INC. 169 BUSINESS OVERVIEW 169 PRODUCTS 169 TABLE 123 HOLOGIC/GENPROBE DIAGNOSTIC PRODUCTS 169 HOME ACCESS HEALTH INC. 169 BUSINESS OVERVIEW 170 PRODUCTS 170 TABLE 124 HOME ACCESS DIAGNOSTIC PRODUCTS 170 IDENIX PHARMACEUTICALS 170 BUSINESS OVERVIEW 170 IMMUNOSTICS 170 BUSINESS OVERVIEW 171 PRODUCTS 171 TABLE 125 IMMUNOSTICS DIAGNOSTIC PRODUCTS 171 IND DIAGNOSTIC INC. 171 BUSINESS OVERVIEW 171 PRODUCTS 172 TABLE 126 IND DIAGNOSTIC PRODUCTS 172 INVERNESS MEDICAL INNOVATIONS (SEE ALERE) 172 IPCA LABORATORIES 172 BUSINESS OVERVIEW 172 JANSSEN THERAPEUTICS (FORMERLY TIBOTEC THERAPEUTICS) 173 BUSINESS OVERVIEW 173 PRODUCTS 173 TABLE 127 JANSSEN THERAPEUTICS PHARMACEUTICAL PRODUCTS 173 MANGALAM DRUGS & ORGANICS LTD. 173 BUSINESS OVERVIEW 173 MEDMIRA INC 174 BUSINESS OVERVIEW 174 PRODUCTS 174 TABLE 128 EDMIRA DIAGNOSTIC PRODUCTS 174 MERCK & COMPANY INC. 174 BUSINESS OVERVIEW 174 PRODUCTS 175 TABLE 129 MERCK VACCINE PRODUCTS 175 TABLE 130 MERCK PHARMACEUTICAL PRODUCTS 175 MERIDIAN BIOSCIENCE 176 BUSINESS OVERVIEW 176 PRODUCTS 176

Global Markets for Infectious Disease Treatments (From Issuu)

Page 15/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! TABLE 131 MERIDIAN BIOSCIENCE DIAGNOSTIC PRODUCTS 176 NOVARTIS CORPORATION 177 BUSINESS OVERVIEW 177 PRODUCTS 178 TABLE 132 NOVARTIS DIAGNOSTIC PRODUCTS 178 TABLE 133 NOVARTIS PHARMACEUTICAL PRODUCTS 178 ORASURE TECHNOLOGIES INC. 178 BUSINESS OVERVIEW 178 PRODUCTS 179 TABLE 134 ORASURE DIAGNOSTIC PRODUCTS 179 ORTHO CLINICAL DIAGNOSTICS 179 BUSINESS OVERVIEW 179 PRODUCTS 179 TABLE 135 ORTHO CLINICAL DIAGNOSTICS DIAGNOSTIC PRODUCTS 179 PARATEK PHARMACEUTICALS 180 BUSINESS OVERVIEW 180 PFIZER INC 180 BUSINESS OVERVIEW 180 PRODUCTS 181 TABLE 136 PFIZER VACCINE PRODUCTS 181 TABLE 137 PFIZER PHARMACEUTICAL PRODUCTS 181 PRINCETON BIOMEDITECH CORPORATION 181 BUSINESS OVERVIEW 181 PRODUCTS 182 TABLE 138 PRINCETON BIOMEDICTECH DIAGNOSTIC PRODUCTS 182 PROTEIN SCIENCES CORPORATION 182 BUSINESS OVERVIEW 182 QUIDEL 183 BUSINESS OVERVIEW 183 PRODUCTS 183 TABLE 139 QUIDEL DIAGNOSTIC PRODUCTS 183 QUIGEN N.V. 183 BUSINESS OVERVIEW 184 PRODUCTS 184 TABLE 140 QUIGEN DIAGNOSTIC PRODUCTS 184 ROCHE LABORATORIES (HOFFMANN-LA ROCHE INC.) 184 BUSINESS OVERVIEW 184 PRODUCTS 185 TABLE 141 ROCHE DIAGNOSTIC PRODUCTS 185 TABLE 142 ROCHE PHARMACEUTICAL PRODUCTS 185 RIB-X PHARMACEUTICALS 185 BUSINESS OVERVIEW 185 ROMARK LABORATORIES 186 BUSINESS OVERVIEW 186 SANOFI PASTEUR 186 BUSINESS OVERVIEW 186 PRODUCTS 187 TABLE 143 SANOFI PASTEUR PHARMACEUTICAL PRODUCTS 187

Global Markets for Infectious Disease Treatments (From Issuu)

Page 16/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! SCICLONE PHARMACEUTICALS 187 BUSINESS OVERVIEW 187 PRODUCTS 188 TABLE 144 SCICLONE PHARMACEUTICAL PRODUCTS 188 SHANGHAI KEHUA BIO-ENGINEERING CO., LTD. 188 BUSINESS OVERVIEW 188 PRODUCTS 188 TABLE 145 SHANGHAI KEHUA BIO-ENGINEERING DIAGNOSTIC PRODUCTS 188 STANDARD DIAGNOSTICS INC 189 BUSINESS OVERVIEW 189 PRODUCTS 189 TABLE 146 STANDARD DIAGNOSTICS DIAGNOSTIC PRODUCTS 189 TETRAPHASE PHARMACEUTICALS 190 TRINITY BIOTECH PLC 190 BUSINESS OVERVIEW 190 PRODUCTS 191 TABLE 147 TRINITY BIOTECH DIAGNOSTIC PRODUCTS 191 VERTEX PHARMACEUTICALS 191 BUSINESS OVERVIEW 191 PRODUCTS 192 TABLE 148 VERTEX PHARMACEUTICAL PRODUCTS 192 VIIV HEALTHCARE 192 BUSINESS OVERVIEW 192 PRODUCTS 193 TABLE 149 VIIV HEALTHCARE PHARMACEUTICAL PRODUCTS 193

LIST OF TABLES SUMMARY TABLE PROJECTED MARKET FOR INFECTIOUS DISEASES DIAGNOSTIC, VACCINE AND PHARMACEUTICAL PRODUCTS BY TYPE, THROUGH 2017 ($ MILLIONS) 7 TABLE 1 GLOBAL PERCENTAGE OF DEATHS BY TYPE OF DISEASE, CAUSE, INCOME LEVEL (%) 11 TABLE 2 SELECTED MAJOR INFECTIOUS DISEASES, WORLDWIDE, 2011 (NUMBER OF CASES, TREATMENT OPTIONS) 11 TABLE 3 VACCINE-PREVENTABLE DISEASE DEATHS IN CHILDREN UNDER 5 YEARS OF AGE BY REGION, 2008 (000) 15 TABLE 4 PROJECTED GLOBAL MARKET FOR HUMAN INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS, THROUGH 2017 ($ MILLIONS) 19 TABLE 5 PROJECTED GLOBAL MARKET FOR HUMAN INFECTIOUS DISEASE VACCINE PRODUCTS, THROUGH 2017 ($ MILLIONS) 20 TABLE 6 PROJECTED GLOBAL MARKET FOR HUMAN INFECTIOUS DISEASE PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 20 TABLE 7 PROJECTED GLOBAL MARKET FOR INFECTIOUS DISEASE DIAGNOSTIC, VACCINE AND TREATMENT PRODUCTS, THROUGH 2017 ($ MILLIONS) 21 TABLE 8 SELECTED MERGERS AND ACQUISITIONS, 2008-2013 ($ MILLIONS) 24 TABLE 9 PROJECTED GLOBAL MARKET FOR INFECTIOUS DISEASE VACCINES,

Global Markets for Infectious Disease Treatments (From Issuu)

Page 17/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! THROUGH 2017 ($ MILLIONS) 26 TABLE 10 VIRUSES, THE DISEASES THEY CAUSE, AND AVAILABLE VACCINES 29 TABLE 11 BACTERIA, THE DISEASES THEY CAUSE, AND AVAILABLE VACCINES 30 TABLE 12 IMMUNIZATION SCHEDULE FOR CHILDREN FROM BIRTH TO 6 MONTHS 31 TABLE 13 IMMUNIZATION SCHEDULE FOR CHILDREN FROM 12 MONTHS TO 4 TO 6 YEARS 31 TABLE 14 IMMUNIZATION SCHEDULE FOR CHILDREN AND ADOLESCENTS FROM 7 TO 18 32 TABLE 15 TOP-SELLING INFECTIOUS DISEASE VACCINES WITH APPLICATION, MANUFACTURER AND REVENUE, 2011 35 TABLE 16 PROJECTED REGIONAL MARKETS FOR VACCINES, THROUGH 2017 ($ MILLIONS) 35 TABLE 17 PROJECTED AMERICAS MARKET FOR INFECTIOUS DISEASE VACCINES BY REGION, THROUGH 2017 ($ MILLIONS) 37 TABLE 18 PROJECTED AMERICAS MARKET FOR INFECTIOUS DISEASE VACCINES BY DISEASE, THROUGH 2017 ($ MILLIONS) 38 TABLE 19 PROJECTED EMRA MARKET FOR HUMAN INFECTIOUS DISEASE VACCINES, BY REGION, THROUGH 2017 ($ MILLIONS) 38 TABLE 20 PROJECTED EMRA MARKET FOR HUMAN INFECTIOUS DISEASE VACCINES, BY DISEASE, THROUGH 2017 ($ MILLIONS) 39 TABLE 21 PROJECTED ASIAN MARKET FOR HUMAN INFECTIOUS DISEASE VACCINES, BY REGION, THROUGH 2017 ($ MILLIONS) 39 TABLE 22 PROJECTED ASIAN MARKET FOR HUMAN INFECTIOUS DISEASE VACCINES, BY DISEASE, THROUGH 2017 ($ MILLIONS) 40 TABLE 23 PROJECTED GLOBAL MARKET FOR VIRAL INFECTIOUS DISEASE DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 43 TABLE 24 PROJECTED GLOBAL MARKET FOR HEPATITIS DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 44 TABLE 25 PROJECTED GLOBAL MARKET FOR HSV DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 45 TABLE 26 CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF GENITAL HERPES BY BRAND NAME, TYPE AND MANUFACTURER, 2012 46 TABLE 27 MEDICATIONS USED TO TREAT HSV BY BRAND NAME, GENERIC NAME AND MANUFACTURER 47 TABLE 28 PROJECTED GLOBAL MARKET FOR HEPATITIS B AND C DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 48 TABLE 29 HEPATITIS B AND C DIAGNOSTIC PRODUCT MARKET SHARE BY TYPE OF TEST AND REVENUES, 2011 ($ MILLIONS/%) 48 TABLE 30 CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF HEPATITIS B AND C BY BRAND NAME AND MANUFACTURER, 2012 49 TABLE 31 HEPATITIS B AND C TREATMENT MANUFACTURER MARKET STANDING, BY REVENUES, 2011 ($ MILLIONS) 51 TABLE 32 MEDICATIONS FOR THE TREATMENT OF HEPATITIS B AND C, 2012 52 TABLE 33 PROJECTED GLOBAL MARKET FOR HIV DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 53 TABLE 34 CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF HPV BY BRAND NAME, TYPE AND MANUFACTURER, 2012 57 TABLE 35 MEDICATIONS USED TO TREAT HPV BY BRAND NAME, GENERIC NAME,

Global Markets for Infectious Disease Treatments (From Issuu)

Page 18/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! AND MANUFACTURER 57 TABLE 36 RSV DIAGNOSTIC PRODUCTS BY BRAND NAME, MANUFACTURER AND TYPE 2012 61 TABLE 37 PROJECTED GLOBAL MARKET FOR VIRAL INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS, THROUGH 2017 ($ MILLIONS) 62 TABLE 38 PROJECTED GLOBAL MARKET FOR VIRAL INFECTIOUS DISEASE PHARMACEUTICAL PRODUCTS, THROUGH 2017 ($ MILLIONS) 62 TABLE 39 PROJECTED GLOBAL MARKET FOR VIRAL INFECTIOUS DISEASE DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 63 TABLE 40 PROJECTED MARKET FOR VIRAL DIAGNOSTIC PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 64 TABLE 41 PROJECTED MARKET FOR VIRAL PHARMACEUTICAL PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 65 TABLE 42 PROJECTED AMERICAS MARKET FOR VIRAL INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 66 TABLE 43 PROJECTED AMERICAS MARKET FOR VIRAL INFECTIOUS DISEASE PHARMACEUTICAL PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 67 TABLE 44 PROJECTED AMERICAS MARKET FOR VIRAL INFECTIOUS DIAGNOSTIC AND PHARMACEUTICAL PRODUCTS, BY DISEASE, THROUGH 2017 ($ MILLIONS) 67 TABLE 45 PROJECTED EMRA MARKET FOR VIRAL INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS BY REGION, THROUGH 2017 ($ MILLIONS) 68 TABLE 46 PROJECTE

Global Markets for Infectious Disease Treatments (From Issuu)

Page 19/21


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ

Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93

If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information Please verify that the product information is correct and select the format(s) you require. Global Markets for Infectious Disease Treatments

Product Formats Please select the product formats and the quantity you require. 1 User License--USD 5 450.00

Quantity: _____

Department License--USD 6 650.00

Quantity: _____

Corporate License--USD 9 350.00

Quantity: _____

Contact Information Please enter all the information below in BLOCK CAPITALS

Title:

Mr

Mrs

Dr

Miss

Ms

Prof

First Name:

_____________________________ Last Name: __________________________________

Email Address:

__________________________________________________________________________

Job Title:

__________________________________________________________________________

Organization:

__________________________________________________________________________

Address:

__________________________________________________________________________

City:

__________________________________________________________________________

Postal / Zip Code:

__________________________________________________________________________

Country:

__________________________________________________________________________

Phone Number:

__________________________________________________________________________

Fax Number:

__________________________________________________________________________

Global Markets for Infectious Disease Treatments (From Issuu)

Page 20/21


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

 

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56

ƒ ƒ

Asia, Oceania and America : + 1 (805) 617 17 93

Global Markets for Infectious Disease Treatments (From Issuu)

Page 21/21


Global Markets for Infectious Disease Treatments